- No public price. Schedule a demo.
- Not disclosed
- Type II
- —
- —

Rivet Health
by Rivet Health
Revenue diagnostics, payer contract management and patient pricing for provider revenue cycles.
On this page
- Regulatory & Compliance6/13.6
Partial attestation (one of HIPAA / SOC2 / BAA)
- Clinical Integration0/31.4
No EHR integrations listed
- Evidence Strength0/10
No peer-reviewed coverage
- Vendor & Market3/18
Seed-stage or unfunded
- Sentiment & Transparency3.3/15.5
Pricing on request, no public amounts
▸ Show all 11 dimensions▾ Hide dimension detail
- FDA clearance0/4
No FDA clearance listed
- HIPAA / SOC2 / BAA6/10
Partial attestation (one of HIPAA / SOC2 / BAA)
- EHR integrations (count)0/18
No EHR integrations listed
- Top-3 EHR coverage (Epic / Oracle / Athena)0/8
None of the top-3 EHRs covered
- Bidirectional write-back0/5
No bidirectional write-back documented
- Peer-reviewed papers0/7
No peer-reviewed coverage
- RCT / meta-analysis / systematic review0/3
No RCT, meta-analysis, or systematic review
- Funding & adoption signal3/12
Seed-stage or unfunded
- Years in market0/6
Founded year not recorded
- Clinician sentiment (Reddit)0/9
No clinician sentiment data available
- Pricing transparency3/7
Pricing on request, no public amounts
Revenue diagnostics, payer contract management and patient pricing for provider revenue cycles.
No public price. Schedule a demo. SOC 2 Type II attested.
Bottom line
Rivet Health, now part of Zelis, sells revenue cycle analytics: denial prevention, payer contract management and underpayment detection, and patient price estimates. It is a billing-office tool and not a clinical one. It suits a practice or billing group on athenahealth, ModMed or AdvancedMD with an underpayment problem. Zelis announced the acquisition in January 2026, and a third-party deep dive expects roadmap, pricing and contract terms to shift.
What is Rivet and who sells it?
Zelis announced the acquisition on 12 January 2026, per Business Wire, and did not disclose terms. Zelis is based in Boston, and HIT Consultant reports the deal built on an existing partnership between the two companies. Zelis says Rivet's analytics reach more than 750 payers.
Before that, Rivet was a Salt Lake City company founded in 2018 by Ted Ferrin, who is CEO, and Andrew Harding, per Crunchbase. Tracxn gives 2017. Menlo Ventures led an $8.25M Series A announced on 10 March 2020. A Series B was reported in June 2022, and LinkedIn lists $20.5M for it. Total funding is $28.8M according to Tracxn and $31.5M according to PitchBook.
Which problems does it address?
The homepage pitches a "Revenue Accelerator Meets Financial X-Ray Vision." It has three product areas.
- Revenue Diagnostics: AI forecasting, drill-down reporting and what the site calls an "AI-powered denials prevention engine."
- Payer Performance: contract management, fee schedules, benchmarking, a scenario simulator and automatic detection of payment variances.
- Patient Pricing: Good Faith Estimates under the No Surprises Act, real-time eligibility checks and easy-pay.
The vendor says it has audited more than 500M claims and remits and handled over $1.6B in patient responsibility. It also claims support responses under 30 seconds and 99.9% uptime. The vendor gives no method for any of these numbers.
Which systems does it connect to?
The homepage says Rivet is "compatible with numerous electronic health record systems, including athenahealth, ModMed, AdvancedMD." Epic and Oracle are not named. A SOC 2 badge appears in the site footer, with no report behind it on the page.
What changes under Zelis?
A deep dive on revcycleai.com warns of integration risk after the deal, with the product roadmap, pricing and contract terms all liable to shift.
How is it priced?
Rivet is priced through a sales call, and the homepage button reads "Schedule a demo."
The verdict
Rivet fits a practice or billing group on athenahealth, ModMed or AdvancedMD that wants payer contract benchmarking and underpayment detection. A group on Epic or Oracle is outside the systems the homepage names. The January 2026 Zelis acquisition puts the standalone product's roadmap and pricing with a new owner.
Editorial review last generated October 15, 2026. Synthesized from clinician sentiment, peer-reviewed coverage, and our editorial silo picks. Refined by hand where vendor facts change.
What it costs
All tiers are custom-quoted. The vendor does not publish per-provider list pricing.
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | — | — | No public price. Schedule a demo. |
Source: vendor pricing page. Last checked October 15, 2026.
What deploys cleanly
Carries SOC 2 (vendor-stated, footer badge only, no report seen) per vendor documentation. Independent attestation review is the buyer's responsibility before clinical deployment.


